I’m interested in cannabis stocks. However, I can’t find any in-depth analysis anywhere, only news articles and blogs where the sources are questionable. Could someone analytically compare different stocks from a business perspective and their valuation levels?
2 Likes
Put your money where your mouth is? ;D
Isohkoja rahoja ja nimijä alalla ainakin liikkuu.
Smells like investors see a very green future for these stocks. Nordnet has been humming about these to retail investors.
Bubble, anyone? 
6 Likes
I wasn’t there to see it then, but is there a bit of the same vibe here as in the tech bubble or before the last crash? 
Everything to the limit? 
5 Likes
I personally took a small slice of HMMJ ETF into my portfolio at the beginning of December, luckily because of MiFID/MiFIR. This is also a high-risk investment, but I’m still smiling…
I wasn’t around during the dot-com bubble, but I’d guess that this isn’t as big of a deal as the tech bubble was. I admit that I personally think the sector is already in a bubble, and I’ve been considering cashing in my profits in recent weeks. At the moment, however, it generally feels very surprising how many different things cannabis or its derivatives can actually be applied to, and what kind of new offerings this creates as medicine or for recreational use.
As for valuations, comparing them to traditional valuation metrics is really pointless at the moment, and the sector is currently dominated by a chess game between various large players. Constellation’s confirmed investment, Coca-Cola is rumored to be interested in investing, and every day it seems like a new major player is showing interest in the sector. The next few years will show which companies are winners and which are not; creative destruction will hopefully reveal that.
1 Like
This thread is quite quiet, considering how much potential there is in the cannabis (MJ) sector. Especially as a long-term investment. Canadian companies are mostly priced quite high already, but for example, ACB and APHA are still without major investors like CGC/TLRY/CRON have. In the US, there are a huge number of companies whose valuations are still low because legislative liberalization is only underway.
4 Likes
Well, I found a thread on the topic here, although not very active
I stumbled upon Aphria’s name in an OP news article a few months ago and started loosely following it, without any open positions at that point. Now there have been two good quarters of results, Cannabis 2.0 is underway, and more legalizations are being discussed (new states across the border, Mexico?).
I took a small opening position a week ago, just to get some motivation to wade through cannabis news in English. Aphria seems profitable at first glance, involved in Cannabis 2.0 (edibles, drinks, etc.), and has contacts in the USA as well. And the share price is even a pleasing single digit for me, a common investor, at the moment 
Is anyone still following the industry? Are we still going to the moon? A new Amazon (mentioned in some article or misread by me)? 
3 Likes
I myself have been actively following the MJ sector for a couple of years now.
Generally speaking, Canadian stock market shares have taken a severe beating, more than anyone probably expected. Little by little, the euphoria has given way to a situation where earnings reports actually matter, and weaker-than-expected results have driven prices down.
Weekly view of price development:
Daily level:
On a daily level, APHA is actually one of the strongest, as it has made an upward reversal, while others are still struggling with it. However, CGC is the market leader, so others tend to follow its price reactions quite strongly.
ACB is clearly the weakest, and CURA is in between. VFF is currently the strongest based on price development. Which companies have you been following more closely? There are plenty of them when you go into smaller ones.
The US sector is still awaiting legislative changes this year. Many have bought initial positions with that in mind, but you never know with politicians.
3 Likes
Thanks for your thoughts and charts! 
I’ve put those three, Aphria, Canopy, and Aurora, on my watch list, as they seem to have more daily volume than others. I only started investing at the beginning of the year, and since I only recently got into cannabis companies, I guess I avoided the first bubble’s crash. Now the air seems to be out of the prices, and maybe we’re at the beginning of a new rise
It seems that the sale of new products in Canada will begin no earlier than December 17th. Add to that some legalization news for this year, and there are at least a few good drivers in place.
1 Like
Aphria Inc. (APHA) announced it has received a cultivation licence from Health Canada for Aphria Diamond, the Company’s second Leamington, Ontario cannabis greenhouse facility, bringing an additional 1,300,000 square feet of production space with an annual growing capacity of 140,000kg. Combined with the Company’s Aphria One facility and its subsidiary Broken Coast Cannabis, the Company now has more than 2,400,000 square feet of cultivation space capable of reaching a total annualized production capacity of 255,000kg.
3 Likes
You should look for discussions on this topic at https://www.reddit.com/r/weedstocks/
If you have enough background information on the industry and companies, then with reservations. There’s a lot of nonsense that can get in there, but that’s the case with all discussion forums, of course.
2 Likes
I’ve also done a very small amount of trading in Cronos. Made good profits back in the day but now the position is in the red, profit probably +/- 0…
I think I’ll add more but drop the losers from the back of the boat using FIFO.
So, I wonder if I should consider getting back on the bandwagon
If we’re not at rock bottom yet, we’re at least close, one could say. But a lot still depends, of course, on how these edibles/drinks - “Cannabis 2.0” - products enter the market in Canada and how their sales take off. In the USA, a decision on the SAFE Act is awaited.
Perhaps, however, there is more upward momentum in the USA, where there is so much more potential. Canada’s population is still small. But concerning CBD, of course, Canadians have spread to Europe, so there are big expectations in this sector.
https://www.marketwatch.com/story/cronos-paid-300-million-for-a-small-cbd-company-and-ceos-private-equity-firm-stands-to-collect-120-million-of-it-2019-11-04
I came across this, so I’m putting it here. Of course, I don’t know the background of this in detail, and sometimes these “news” stories contain exaggerations, but it’s undeniable that the MJ sector has been plagued by these types of things all along. Those who have followed APHA probably understand the cough. Investors have had to be on edge, wondering when something negative would hit their own targets, and if their portfolio was broad, they couldn’t avoid these. Or various financing schemes that have severely diluted the stock’s value.
GWPH, by the way, dropped about 15% in post-market due to earnings.
Ouch! Not a good look for Cronos’s CEO